View Annual report NDC 2025 complete flipbook.
Chantelle Duncan 1 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025
Chantelle Duncan 2 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 TABLE OF CONTENTS LIST OF ACROYNMS .................................................................................................................................................... 3 FOREWORD ................................................................................................................................................................. 5 EXECUTIVE SUMMARY ................................................................................................................................................ 6 OVER VIEW OF THE NATIONAL DRUG COUNCIL........................................................................................................ 7 ACTIVITIES OF THE COUNCIL .................................................................................................................................... 12 INTERNATIONAL COOPERATION ............................................................................................................................... 16 ACHIEVEMENTS OF THE NATIONAL DRUG COUNCIL ..................................................................................... 26 FINANCIAL REPORT AND BUDGET OVERVIEW ......................................................................................................... 28 THE WAY FORWARD .............................................................................................................................................. 29 CONCLUSION .......................................................................................................................................................... 31 APPENDIX I ................................................................................................................................................................ 32 APPENDIX II ................................................................................................................................................................ 33
Chantelle Duncan 3 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 LIST OF ACROYNMS ADAPP ATI Alcohol and Drug Abuse Prevention Programme Alternatives to Incarceration CAPA CARICOM Crime and Problem Analysis Branch Caribbean Community CCITS Caribbean Counterdrug Intelligence Training School CCM Case Care Management CICAD CND Inter-American Drug Abuse Control Commission Commission on Narcotic Drugs CSO Central Statistical Office COPOLAD Cooperation Programme between Latin America, Caribbean and the European Union on Drugs and Policies DIN TT Drug Information Network of Trinidad and Tobago DTC Drug Treatment Centre ECOSOC Economic and Social Council EWS EU FIB Early Warning Systems European Union Financial Investigation Branch FIUTT Financial Intelligence Unit of Trinidad and Tobago FOCTALI Strengthening Therapeutic Communities and Treatment Centers in Latin America and the Caribbean with Italian Support GENLEA INCB Gender Equality in Counterdrug Law Enforcement Agencies International Narcotics Control Board LAC MEM NADAPP NDC NDCTT Latin America and the Caribbean Multilateral Evaluation Mechanism National Alcohol and Drug Abuse Prevention Programme National Drug Council National Drug Council Trinidad and Tobago
Chantelle Duncan 4 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 LIST OF ACROYNMS PRTU Penal Reform and Transformation Unit RSA Rapid Situational Assessment SERVOL SSA SIU SUD Service Volunteered for All Strategic Services Agency Special Investigations Unit Substance use disorder THA Tobago House of Assembly TOR Terms of Reference TYC TOCU UN Trinidad Youth Council Transnational Organized Crime Unit United Nations UNDCP UNODC United Nations Drug Control Programme United Nations Office on Drugs and Crime USC University of the Southern Caribbean UTT University of Trinidad and Tobago UWI University of the West Indies YTC Youth Training Centre YTEPP Youth Training and Employment Partnership Programme
Chantelle Duncan 5 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 FOREWORD This report highlights our major initiatives, accomplishments, and the ongoing efforts to enhance national strategies in drug control, prevention, and rehabilitation. Throughout 2025, we remained steadfast in our commitment to implementing evidence-based strategies that address the complex challenges of substance use and misuse. We have expanded prevention programs, improved access to treatment, and worked collaboratively to address the root causes of addiction. With a data driven and people centered approach, we have prioritized education, recovery support, and policies that reduce harm while fostering long term well-being. While we celebrate the progress made, we recognize that our work is far from over. Combatting substance misuse and abuse requires a united effort, one that brings together government agencies, healthcare professionals, law enforcement, community organizations, private sector and the citizenry of Trinidad and Tobago. By strengthening our partnerships and remaining focused on sustainable solutions, we can continue to make meaningful strides toward a healthier and more resilient society. As we look ahead to 2026, we are confident that the Council will build on its successes, advancing policies and programs that empower individuals and communities. With renewed dedication, we will navigate the challenges ahead, ensuring that every step we take moves us closer to a future where prevention, treatment, and support systems are accessible to all. We extend gratitude to our partners, stakeholders, and citizens who share in this mission. Your commitment and collaboration are the driving forces behind our progress. Let us move forward together, strengthening our collective resolve to create a society where every individual has the opportunity to lead a healthier, life.
Chantelle Duncan 6 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 EXECUTIVE SUMMARY The 2025 Annual Report of the National Drug Council of Trinidad and Tobago (NDCTT) presents a comprehensive overview of the Council’s accomplishments, strategic initiatives, and ongoing challenges over the past year. In 2025, following a change in government, the NDC TT underwent a change, to the Ministries of Homeland Security and Defence. Despite this administrative shift, the NDC TT’s core mandate, to guide national drug policy and coordinate drug control efforts, remained unchanged. Throughout the year, the NDCTT remained firmly committed to fulfilling this mandate. It successfully concluded oversight of the Operational Plan for Drug Control 2021–2025, while simultaneously leading the development of a new, forward-looking policy framework to guide the next phase of national drug control efforts including a monitoring and evaluation component. A key focus of the NDCTT Secretariat in 2025 was the monitoring and evaluation (M&E) of the 2021–2025 Operational Plan as it reached its final stages. This involved assessing implementation outcomes, identifying lessons learned, and enhancing M&E capacity across the plan’s thematic pillars. These efforts informed the creation of the new National Drug Policy and Operational Plan, designed to address emerging trends and national priorities. The ongoing rebranding of the NDCTT, which began in 2023, continued to progress in 2025. This transformation reflects the Council’s evolving role and its increased emphasis on stakeholder collaboration and responsiveness to dynamic drug-related challenges. Significant advances were also made in the operational development of the Drug Information Network of Trinidad and Tobago (DIN-TT). Quarterly meetings with the Technical Committee and Stakeholder Group were maintained, and DIN-TT successfully published its 10th Annual Report, while exploring new avenues for data integration and future growth. Additionally, the NDCTT facilitated multiple workshops, webinars, and training sessions in collaboration with international partners such as OAS/CICAD and COPOLAD. These capacity- building initiatives reinforced international partnerships and enriched the expertise of stakeholders involved in national drug control efforts. This report not only outlines the achievements under the 2021–2025 Operational Plan but also provides a foundation for implementation of the newly developed strategic framework in the years ahead, thereby promoting continuity, adaptability and resilience in national drug control efforts an evolving institutional landscape.
Chantelle Duncan 7 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 OVER VIEW OF THE NATIONAL DRUG COUNCIL Establishment of the National Drug Council The Government of the Republic of Trinidad and Tobago (GORTT) on July 05, 2000, by Cabinet Minute #1231 established the National Drug Council. This was in alignment with the internationally recommended structure for a national entity with responsibility for overseeing the implementation of all aspects of drug control. The Government of Trinidad and Tobago established the Council with primary responsibility for: The Cabinet approved Mandate is attached at Appendix I. Membership of the National Drug Council Trinidad and Tobago The Council comprise the Chair and thirteen (13) representatives from Ministries, drug demand and supply reduction agencies, non-governmental agencies (NGO), the Tobago House of Assembly (THA), and the business community. The members of the Council function at the level of the highest decision-makers in agencies with responsibility for Drug Control. The current membership of the Council is attached at Appendix II. Advising on policy Monitoring the implementation of the various Anti-Drug Plans Coordinating activities which require contributions from principal agencies Liaising with local and regional stakeholders and the international community
Chantelle Duncan 8 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Meetings of the National Drug Council Throughout 2025, the National Drug Council convened on a monthly basis to address ongoing matters related to drug control and policy implementation. Meetings were hosted both virtually and in person, ensuring continuity and broad participation from stakeholders. The Council remained focused on monitoring drug trends, coordinating inter-agency efforts, evaluating the effectiveness of national strategies, and advising on critical interventions to reduce drug demand and supply. Regular engagement allowed for timely responses to emerging issues and reinforced the Council’s commitment to evidence-based policymaking and collaborative action. Meetings scheduled for the final quarter of 2025 were postponed due to the absence of a duly appointed chairperson following the conclusion of Mrs. Jennifer Boucaud-Blake’s tenure in September 2025. REPRESENTATIVE/ AGENCY ON THE COUNCIL NUMBER OF MEETINGS ATTENDED NUMBER OF MEETINGS EXCUSED Chair 9 0 Director of Public Prosecution 7 2 Commissioner of Police 6 3 Executive Director, National Security Secretariat 8 1 Director, SSA 7 2 Director (Ag.) Financial Intelligence Unit (FIUTT) 6 3 Comptroller of Customs and Excise 9 0 Director, Multilateral Relations, Ministry of Foreign and CARICOM Affairs 7 2 Coordinator, NADAPP 9 0 Representative of the THA- Coordinator, Planning, and Development, Tobago House of Assembly 8 1 Manager, NDC Secretariat 9 0 CEO, Rebirth House 8 1
Chantelle Duncan 9 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 President, National Council on Alcohol and Other Addictions 7 2 Representative, Chamber of Industry and Commerce 0 9 Representative of the Ministry of People, Social Development and Family Services 8 1 The National Drug Council Secretariat Established in 2001, the National Drug Council Secretariat functions as the operational arm of the Council. It is responsible for implementing the Council’s decisions and managing day-to-day activities in support of its mandate to promote a coordinated and effective national drug control strategy. The Secretariat continued to operate under the leadership of Mrs. Cheryl St Louis-Felix, who has served as Manager since February 2022. Under her guidance, the Secretariat facilitated the Council’s meetings, supported programme development, maintained inter-agency coordination, and ensured ongoing research and public outreach activities. As of 2025, the Secretariat's staffing structure included the following positions: • Manager • Programme Officer • Research Assistant • Business Operations Assistant I • Business Operations Assistant II • Policy Analyst Trainee (On-the-Job Training – OJT) • Communications Assistant (On-the-Job Training -OJT) • Driver / Courier
Chantelle Duncan 10 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 In 2025, the Secretariat experienced several significant staffing changes. The tenure of the assigned driver/courier ended in September 2025, as well as the Business Operations Assistant II (BOA II) in October 2025, both members of staff opted to retire at this juncture in their careers. The Secretariat welcomed Ms. Geneva Windsor, who was previously assigned to the Ministry’s Human Resources Department as the new Business Operations Assistant II (BOA II). Additionally, due to a wider restructuring within the Ministry, the Business Operations Assistant I (BOA I) was reassigned to the Ministry of Defence, Human Resources Department. The tenure of the Communications assistant also ended in December 2025. Despite these changes, the Secretariat continued to function efficiently, maintaining core administrative and operational support to the Council. Through effective coordination the team ensured the uninterrupted delivery of services such as facilitating meetings, document preparation and inter-agency communication. These developments highlighted the Secretariat’s adaptability and its integral role in supporting the Council’s mandate. It is also important to note that the position of Research Specialist has remained vacant since March 2025, following the resignation of the officer. In order to maintain the momentum of ongoing research and data-related activities, the responsibilities of this role were redistributed. The Research Assistant, in collaboration with the Programme Officer, have provided critical support to ensure continuity in data collection, analysis, and reporting functions during this period. While significant changes have taken place not only within our unit but also across the wider Ministry, our mandate remains Picture 1 The staff of the National Drug Council Secretariat at a staff function held in honour of retiring team members in October 2025 Picture 2 Staff members of the National Drug Council Secretariat pictured with the Manager Mrs. Cheryl St. Louis- Felix (extreme left) and the former Chair of the National Drug Council Mrs. Jennifer Boucaud- Blake (extreme right) at the Gender in the Criminal Justice System Workshop in September 2025.
Chantelle Duncan 11 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 unchanged. We continue to be guided by our core mission and remain steadfast in our commitment to delivering results with integrity, consistency, and purpose. Change may alter our path, but not our destination. As the saying goes, "A bend in the road is not the end of the road... unless you fail to make the turn" and we are making that turn with focus and resilience.
Chantelle Duncan 12 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 ACTIVITIES OF THE COUNCIL Annual Meeting In March 2025, the National Drug Council of Trinidad and Tobago (NDC TT) convened its Annual Meeting under the theme “Pillar Talk II”, bringing together key national and international stakeholders to review progress under the Operational Plan for Drug Control (2021–2025) and to begin shaping the strategic direction of national drug policy beyond the current planning cycle. The meeting served as a critical forum for reflection, accountability, and forward planning, as stakeholders examined achievements to date and contributed to discussions on the development of a new National Drug Plan for 2026–2030. Building on the momentum generated by the inaugural Pillar Talk session, this year’s meeting provided a structured yet open platform for dialogue and strategic reflection across the four thematic pillars of the Operational Plan: Prevention; Treatment and Rehabilitation; Supply Reduction; and Institutional Strengthening. Through guided discussions and presentations, participants assessed progress made within each pillar, shared best practices and innovative approaches, and identified persistent gaps and emerging challenges as the 2021–2025 cycle approached its conclusion. A central focus of the meeting was the monitoring and evaluation of the existing Operational Plan. Presentations highlighted key accomplishments, lessons learned, and data-driven insights drawn from implementation across multiple sectors. These discussions underscored the importance of evidence-based decision-making and strengthened coordination in measuring impact, informing policy adjustments, and ensuring accountability. The meeting therefore functioned as a consultative step in refining national priorities and informing the design of the forthcoming National Drug Plan (2026–2030). “Pillar Talk II” also emphasized the value of collaborative and multi-sectoral approaches to drug control. Active engagement from government ministries and agencies, civil society organizations, treatment service providers, and international partners enriched the discussions and reinforced the shared responsibility required to address complex drug related issues. Stakeholders explored innovative strategies, identified capacity building and resource needs, and reaffirmed their collective commitment to a balanced, integrated, and people-centred response grounded in public health, public safety, and human rights principles. Picture 3 Mr. Kendal Fontenelle Master of Ceremonies for the Annual Meeting which was held at Cascadia Hotel in March 2025.
Chantelle Duncan 13 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Overall, the Annual Meeting reaffirmed the NDC TT’s role as a coordinating, policy driven, and convening body, fostering transparency, inclusion, and strategic alignment among stakeholders. As the country transitions into the next phase of its drug control efforts, the outcomes of “Pillar Talk II” will contribute to guiding national policy development and strengthening Trinidad and Tobago’s comprehensive and evidence-based response to drug related challenges.
Chantelle Duncan 14 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 International Day Against Drug Abuse and Illicit Trafficking The United Nations Office on Drugs and Crime (UNODC) is the body tasked with the responsibility for identifying, developing and implementing projects and programmes which address issues related to drugs in the areas of supply and demand reduction and its accompanying issues. Among its various initiatives, the UNODC recognizes International Day against Drug Abuse and Illicit Trafficking on June 26 annually. The theme for the year 2025/2026 is ‘The Evidence is clear: Breakthecycle#StopOrganizedCrime’. In observance of the International Day Against Drug Abuse and Illicit Trafficking 2025, the National Drug Council of Trinidad and Tobago (NDC TT) disseminated an official statement from the Minister of Defence and the Minister of Homeland Security on June 26, 2025. This statement aimed to highlight the significance of the day, promote national awareness, and encourage collaborative efforts in addressing drug use and abuse and illicit trafficking. The statements underscored this year’s global theme and reinforced the need for unified action in building a healthier, safer society. By circulating the message among key government stakeholders, as well as to the wider public via the social media pages the NDCTT sought to ensure that the importance of prevention, treatment, and law enforcement remained at the forefront of national priorities.
Chantelle Duncan 15 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 UNiTE to End Violence against Women Campaign The UNiTE to End Violence against Women initiative is a multiyear global effort to prevent and eliminate violence against women and girls. Launched in 2008 under the leadership of the United Nations Secretary-General, the initiative supports the civil- society-led 16 Days of Activism against Gender- based Violence campaign worldwide. In 2025, during the 16 Days of Activism from 25 November to 10 December, the UNiTE campaign highlighted the alarming escalation of violence against women and girls under the theme “End digital violence against all women and girls.” Gender-based violence, including digital violence, is increasingly recognized as a cross-cutting issue that intersects with transnational organized crime, including drug trafficking. In line with UNODC and NDC approaches, women and girls are individuals who may be disproportionately exposed to risk due to structural inequalities, coercion, exploitation, and limited access to protection mechanisms. Criminal networks often exploit these vulnerabilities, including through digital means, to recruit, control, or coerce women into acting as drug carriers or facilitators. From a drug control and prevention perspective, addressing violence against women is essential to reducing vulnerability to exploitation by organized crime. Gender responsive drug control strategies emphasize prevention, early identification of risk factors, protection of vulnerable populations, and access to support services. Integrating a gender perspective into drug control policies strengthens both crime prevention and public health outcomes, while upholding human rights and the principles of proportionality and non-discrimination. The UN Secretary-General’s UNiTE by 2030 to End Violence against Women campaign uses the colour orange as a symbol of hope and a future free from violence against women and girls. In solidarity with the campaign, staff of the NDC Secretariat participated in the 2025 16 Days of Activism by wearing orange. This visible show of support underscored the Secretariat’s commitment to promoting gender-responsive approaches within drug control efforts, raising awareness of the links between gender-based violence and drug related exploitation, and contributing to prevention oriented, victim centred, and rights-based responses. Picture 4 Staff from the NDC wearing orange in solidarity for the UNiTE End to Violence against Women Initiative
Chantelle Duncan 16 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 INTERNATIONAL COOPERATION COPOLAD III Regular Session A delegation from Trinidad and Tobago comprising the Chair of the National Drug Council Mrs. Jennifer Boucaud-Blake, the Manager of the National Drug Council Mrs. Cheryl-Ann St. Louis- Felix and Ms Tiffany Bethel, First Secretary, Embassy of Trinidad and Tobago to the Kingdom of Belgium and Mission to the European Union represented Trinidad and Tobago at COPOLAD III in Warsaw Poland in May 2025. Building on the progress made in the previous stages, COPOLAD III continues to promote technical cooperation as well as political dialogue between Latin America, the Caribbean and the EU, to support the region in the implementation of more effective drug policies and with results that substantially improve the lives of people and, especially, of the most vulnerable. COPOLAD III combines the now traditional bi-regional and multi-country collaboration spaces with direct technical assistance interventions to meet national needs and promote transformative and innovative interventions, mobilising European, Latin American and Caribbean public expertise in bilateral, triangular and South-South cooperation schemes. The COPOLAD III Annual Meeting, under the slogan ‘A common challenge, a shared strategy’, has two strategic objectives. On the one hand, to strengthen the bi-regional space for dialogue on drug policies, seeking convergence and harmonization in shared strategies. In this regard, Picture 5 Delegates who participated in COPOLAD III in Warsaw Poland in May 2025 at a round table discussion. Picture 6 The Manager of the National Drug Council Mrs. Cheryl St.Louis-Felix attends COPOLAD III in Warsaw Poland in May 2025
Chantelle Duncan 17 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 both co-chairs of the EU-CELAC Drug Coordination Mechanism and the countries are involved in the preparation of the technical discussions, ensuring the connection of these bodies with the work of the Mechanism, which will meet the following day, May 08, in Warsaw, Poland. COPOLAD III Annual Meeting serves as a space for accountability and exchange of experiences among the Program’s allies and partner countries in Latin America and the Caribbean and the European Union. It also serves to highlight COPOLAD’s added value in its comprehensive approach, covering the areas of supply and demand reduction, peer learning, the multi-actor and territorial approach to the drug phenomenon, gender and human rights. Picture 7 COPOLAD III Meeting in Warsaw Poland May 2025
Chantelle Duncan 18 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Alternative Development Dominican Republic In 2025, the Alternative Development Initiative continued to advance its mandate of promoting sustainable livelihoods and reducing the vulnerabilities that drive communities toward illicit economies. The programme focused on strengthening community resilience, expanding economic opportunities, and supporting local stakeholders in adopting viable, long-term alternatives that contribute to social and economic stability. Throughout the year, the initiative worked closely with local authorities, community leaders, and civil society partners to implement community- driven projects aimed at improving income generation, enhancing access to services, and fostering inclusive development. Capacity building activities, skills training, and small- scale enterprise support remained central components of the programme, empowering households particularly women and youth to transition toward more sustainable sources of income. Overall, the Alternative Development Initiative made significant progress in enhancing community well-being, promoting economic diversification, and supporting national efforts to address the root causes of vulnerability and illicit activity. Picture 8 Delegates from the Alternative Development meeting held in the Dominican Republic.
Chantelle Duncan 19 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Alternative Development Peru The Trinidad and Tobago delegation participated in the 10th Expert Group Meeting on Alternative Development which was convened to advance discussions on complementing and strengthening the implementation of the United Nations Guiding Principles on Alternative Development. The meeting brought together high-level government representatives, international organizations, development partners and subject matter experts to share policy experiences, emerging research and practical innovations related to sustainable and inclusive alternative development approaches Participation in the EGM on AD provided valuable exposure to current international policy debates, best practices and emerging research related to alternative development. The insights gained are relevant for strengthening national and regional approaches to drug control, sustainable livelihoods and inclusive development programming in Trinidad and Tobago. The meeting also facilitated networking with international partners and experts, supporting future collaboration and knowledge exchange. The 10th Expert Group Meeting on Alternative Development served as a comprehensive platform for advancing dialogue on complementing the UNGP on AD in response to evolving global challenges. The discussions reinforced the importance of inclusive, evidence-based, and context-sensitive approaches to alternative development. Overall, the engagement contributed positively to institutional learning and supports ongoing efforts to align alternative development initiatives with sustainable development and human-centered policy objectives. Picture 9 Delegates from the 10th Expert Meeting on Alternative Development meeting in Peru
Chantelle Duncan 20 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 High Level Seminar of EU-CELAC National Drug Agencies Brussels The High-Level Seminar of EU and CELAC National Drug Agencies on Common Challenges in the Drug Sector hosted in Brussels, 9 to 11 December 2025 was focused on shared operational, methodological, and strategic challenges faced by national drug centres. The meeting convened representatives’ international bodies to examine current developments in drug monitoring, information systems, and evidence-based responses to drug-related harms. Key areas of discussion included the harmonisation of data collection methodologies, quality assurance and comparability of national datasets, and the integration of multiple data sources to improve the timeliness and accuracy of drug trend analysis. Particular attention was given to challenges related to emerging psychoactive substances, polysubstance use, and rapidly changing drug markets, as well as the implications of these trends for early warning systems and risk assessment processes. Participants also explored the capacity of national drug agencies to respond to increasing reporting demands, evolving European monitoring frameworks, and the need for sustainable resources and skilled analytical expertise within national drug centres. The meeting highlighted the importance of cross- national collaboration, knowledge exchange, and coordinated Picture 10 Participants of the National Drug Agencies on Common Challenges in the Drug Sector in Brussels. Picture 11 The Manager of the National Drug Council Ms. Cheryl St. Louis Felix presenting at the panel in Brussels
Chantelle Duncan 21 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 approaches to address shared challenges and to support coherent policy development at both national and European levels. Attendance at this meeting contributed to strengthening institutional networks, enhancing awareness of emerging methodological developments, and ensuring alignment with European standards and priorities in drug monitoring and reporting.
Chantelle Duncan 22 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Gender in the Criminal Justice System Alternatives to Incarceration for Drug-Related Offenses Through the “Gender in the Criminal Justice System” project, in collaboration with the Executive Secretariat of the Inter-American Commission the Executive Secretariat of CICAD seeks to generate data, raise awareness, and build capacity to promote the design and implementation of gender-sensitive alternatives to incarceration (ATI) programs and policies in OAS Member States. As part of the ongoing commitment to advancing inclusive and evidence-based drug policies, the National Drug Council partnered with the OAS/CICAD to host a three-day initiative under the Gender in the Criminal Justice System program. This initiative was based on the outcome of a diagnostic study undertaken and funded by OAS/ CICAD titled Gender in the Criminal justice system. The study brought together key national stakeholders from across the criminal justice, health, and social service sectors to explore the intersection of gender, drug policy, and criminal justice reform. The workshop, hosted over two days, served as a collaborative platform for dialogue, knowledge sharing, and the development of a practical and context- specific action plan aimed at implementing the Gender in the Criminal Justice System program locally. Participants engaged in focused discussions on policy gaps, systemic challenges, and opportunities for gender-sensitive reform across the criminal justice continuum. This event provided a unique forum for open discussion on the growing concerns surrounding gender dynamics and the emergence of New Psychoactive Substances. Stakeholders from government agencies, civil society, academia, and Picture 12 Participants from stakeholder agencies participate in the two-day workshop for Gender in the Criminal Justice system in partnership with OAS/CICAD in September 2025
Chantelle Duncan 23 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 community organizations participated in a vibrant dialogue that emphasized the importance of coordinated, gender-responsive strategies in addressing these evolving challenges. This initiative marked a critical step forward in fostering multi- sectoral collaboration, raising awareness, and advancing our national agenda on gender equity within the drug and criminal justice frameworks. The outcomes of the workshop and panel discussion will guide future policy development and program implementation, ensuring that our responses to drug- related issues are inclusive, informed and effective. The workshop concluded with a one-day public engagement event, featuring a panel discussion titled "Block Talk". This featured a dynamic panel discussion on real conversations about drug use, prevention, peer pressure, mental health, and opportunities for youth engagement creating a more relaxed and community-friendly atmosphere. Bringing together key stakeholders, youth representatives, educators, and members of the wider community. With a specific focus on youths, the event was scheduled for September 2025, when schools were in full session, to ensure meaningful participation from students and educational institutions. “Block Talk” aimed to move away from traditional formal settings and instead create a space where young people felt comfortable engaged asked questions, and shared their views. Picture 13 From left to right Scantlebury, Lt. Colonel Michael Jones CARICOM IMPACS, Air Vice Marshall Mr. Darryl Daniel, Permanent Secretary Ministry of Justice Mr. Narine Charran, Permanent Secretary Ministry of Homeland Security Mr. Videsh Maraj, former chairperson NDC Mrs. Jennifer Boucaud-Blake, Marina Piper, Commissioner of Police Allister Guevarro
Chantelle Duncan 24 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 United Nations Office on Drugs and Crime (UNODC) sixty-eight session of the Commission on Narcotic Drugs VIENNA, AUSTRIA Trinidad and Tobago participated in the 64th session of the United Nations Commission on Narcotic Drugs (CND), held in Vienna Austria in March 2025. This engagement formed part of the country’s ongoing representation on the Commission, to which it was elected for a four-year term commencing in January 2022 and concluding in December 2025. Trinidad and Tobago’s membership on the Commission on Narcotic Drugs is of strategic importance, as it is the only CARICOM and English- speaking Caribbean Member State represented on this principal policy-making body of the United Nations system on drug-related matters. This position provides a critical platform to influence the development of global drug policy, advocate for Caribbean and regional priorities, and promote approaches that are responsive to the unique social, economic, and security challenges faced by Small Island Developing States (SIDS). Membership also facilitates access to technical assistance, capacity building opportunities, and alternative resources to strengthen national and regional drug control efforts. During the 64th session, Trinidad and Tobago actively engaged in deliberations on emerging challenges posed by synthetic drugs, including their production, trafficking, and associated public health and security risks. The country supported international efforts aimed at strengthening control mechanisms, improving early warning systems, and promoting coordinated responses to the rapidly evolving synthetic drug market. Discussions on narco-trafficking and transnational organized crime provided an opportunity for Trinidad and Tobago to advance regional perspectives on enhancing border security, intelligence sharing, and international cooperation. Emphasis was placed on the need for integrated
Chantelle Duncan 25 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 approaches that address drug trafficking as a key driver of broader security threats within the Caribbean and beyond. The session also highlighted the importance of building capacity for law enforcement agencies and prevention programmes, particularly in developing regions. Trinidad and Tobago underscored the value of technical assistance, training, and evidence-based prevention strategies to strengthen national institutions, reduce drug demand, and enhance community resilience. At the conclusion of the 64th session, Trinidad and Tobago was re-elected to the Commission on Narcotic Drugs for an additional four-year term, reflecting continued confidence by the international community in the country’s leadership and constructive engagement in global drug policy discussions. This re-election reaffirms Trinidad and Tobago’s commitment to multilateral cooperation, advancing regional security, and contributing to collective efforts to counter transnational crime.
Chantelle Duncan 26 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 ACHIEVEMENTS OF THE NATIONAL DRUG COUNCIL DIN TT Newsletter In 2025, DIN TT published a dedicated newsletter providing an overview of its activities and developments throughout the year. The newsletter served as a key communication tool, highlighting ongoing initiatives, progress in technical work, and engagement with stakeholders. It offered readers insight into DIN TT’s priorities, achievements, and contributions, supporting transparency and knowledge sharing across the community. A broad range of topics were covered in the newsletter, including, updates on technical projects, collaboration with partners, and participation in relevant initiatives and events. It also highlighted milestones reached during the year, showcased selected outcomes of DIN TT’s work, and provided insight into future-oriented topics and emerging areas of activity. By consolidating information in an accessible format, the newsletter strengthened engagement with stakeholders and reinforced DIN TT’s role as a central point of coordination and information. Through this publication, DIN TT reinforced its commitment to keeping members, stakeholders and the general public informed about its work and strategic direction.
Chantelle Duncan 27 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Precursor Chemicals (no.2) Bill Committee The NDC TT, as the coordinating body for national drug policy, is responsible for leading efforts that strengthen institutional responses to drug supply and demand. In this capacity, the NDC TT is tasked with advancing strategic interventions that align with the National Drug Plan and ensure that enforcement, public health, and forensic strategies remain current and effective. The Dangerous Drugs Act, the Pesticides and Toxic Chemicals Act, and the Food and Drugs Act currently provide limited measures to regulate precursor chemicals, however, these frameworks are insufficient and do not fully align with international best practices. The Precursor Chemicals (No. 2) Bill 2014 was introduced in the Senate in 2014. Precursor chemicals are essential components in the manufacture of illicit drugs such as cocaine, heroin, and synthetic narcotics. These substances, while often used in legitimate industrial and commercial activities, have been increasingly diverted for illegal purposes. The Government of the Republic of Trinidad and Tobago (GORTT) has committed to combating the illicit drug trade as part of its international obligations, including adherence to the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 (Vienna Convention). The NDC TT spearheaded the formulation of the Multi-Agency Precursor Chemical Bill Committee which was approved by Cabinet. This committee comprise experts from key government agencies The Ministry of Health, The Ministry of Agriculture and Fisheries, The Ministry of Trade, Investment and Tourism, The Ministry of Justice- Forensics Science Centre. This task force was created to ensure that the legislative framework remains relevant, up to date and effectively supports the regulation and control of precursor chemicals. Once enacted, the Bill is expected to reinforce national compliance with international standards and improve the integrity of chemical control systems on precursor chemicals.
Chantelle Duncan 28 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 FINANCIAL REPORT AND BUDGET OVERVIEW The National Drug Council remains committed to the responsible and transparent management of public funds in pursuit of its strategic objectives. The budget for the fiscal year 2025 was designed to support the strategic priorities of the NDCTT, focusing on innovation and financial sustainability. It was aligned with the long-term objectives and set with the aim to effectively allocate resources across key initiatives. Despite fiscal constraints with the recent change in ministerial over heads, the Council worked diligently to maximize the impact of available resources. Emphasis was placed on cost-effective measures, leveraging partnerships, and identifying opportunities for technical and financial support through regional and international collaborations both existing and new partnerships. The Council will continue to monitor expenditures closely, assess funding gaps, and advocate for the necessary resources to support future initiatives under the next policy cycle. Looking ahead, the Council remains focused on strengthening financial planning and sustainability, ensuring that all efforts are both impactful and accountable. Our goal is to ensure that every dollar spent contributes meaningfully to the national effort to reduce the harms associated with drug use and promote healthier communities across the country.
Chantelle Duncan 29 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 THE WAY FORWARD As we look ahead to 2026, our focus remains firmly on strengthening national drug control efforts through strategic policy development, collaboration, and coordinated action. The coming year presents important opportunities to build on the progress made and to reinforce our commitment to public health, safety, and national security. A key priority for the year will be the development and implementation of a new National Drug Plan and Policy 2026- 2030, which will guide the drug control framework. This plan will emphasize a balanced and evidence-based approach that integrates supply reduction, demand reduction, treatment, rehabilitation, and alternatives to incarceration initiatives. Through this updated policy framework, we aim to ensure that national responses to drug-related challenges remain relevant, coordinated, and responsive to emerging trends. We look forward to continued collaboration with regional and international partners such as CARICOM, OAS/CICAD and COPOLAD, these partnerships allow us to benefit from shared expertise, technical assistance, and intelligence exchange and remain vital in addressing the increasingly transnational nature of drug control issued and the rise in synthetic drugs. The National Drug Council will maintain its commitment to ongoing drug control matters, including monitoring emerging drug trends, supporting inter-agency coordination, strengthening enforcement and regulatory systems, and promoting public awareness initiatives. These efforts will ensure that national drug control strategies remain proactive, comprehensive, and responsive to evolving challenges. As we advance, our success will continue to depend on collaboration, innovation, and sustained commitment. By working closely with our partners at the national, regional, and international levels, we remain confident in our ability to advance a coordinated and effective response to the complex challenges posed by drugs and related illicit activities. Together, we will continue to build a stronger, safer, and more resilient framework for drug control in the years ahead.
Chantelle Duncan 30 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025
Chantelle Duncan 31 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 CONCLUSION This Annual Report reaffirms the National Drug Council’s steadfast commitment to overseeing the implementation of the National Drug Policy and Operational Plan 2021–2025. Despite challenges throughout the year, the Council has remained focused on its mandate working collaboratively with stakeholders and advocating for evidence-based policies and legislation that promote national well-being. A major focus for the reporting period was the continued monitoring of the Operational Plan’s implementation. This process remained on track, with a comprehensive review of achievements scheduled for completion in the last quarter of 2025. While meaningful progress has been made, we acknowledge that certain areas require deeper focus. Delays in programme implementation and the ongoing need for stronger inter-agency collaboration are not setbacks, but opportunities to refine our strategies and strengthen partnerships. We extend sincere appreciation to our stakeholders for their continued support and engagement. As we look ahead, we are energized by the upcoming initiatives designed to expand prevention and treatment efforts, enhance outreach, and reinforce policy development rooted in research and community voices. As we advance into 2026, we remain unwavering in our mission. Grounded in evidence and driven by collaboration, we will continue to build a healthier, safer future for all, one step, one partnership, and one innovation at a time.
Chantelle Duncan 32 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 APPENDIX I
Chantelle Duncan 33 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 APPENDIX II THE MEMBERSHIP OF THE NATIONAL DRUG COUNCIL AS AT DECEMBER 31,2025 Mrs. Jennifer Boucaud- Blake Chairperson (Tenure ended in September 2025) Mr. Allister Guevarro Commissioner of Police Trinidad and Tobago Police Service, Ministry of National Security Ms. Alicia Henry Director, Strategic Services Agency, Ministry of National Security Mr. Roger Gaspard Director of Public Prosecutions Mrs. Gillian Gellizeau- Menzies CEO, National Security Council, Secretariat, Office of the Prime Minister Mr. Riad Juman Comptroller of Customs and Excise, Ministry of Finance Mr. Garvin Pettier Director, Multilateral Relations Division, Ministry of Foreign and CARICOM Affairs Mr. Nigel Stoddard Director, Financial Intelligence Unit, Ministry of Finance Mrs. Wendy Guy- Hernandez Senior Planning Officer, Ministry of People, Social Development and Family Services
Chantelle Duncan 34 NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO ANNUAL REPORT – 2025 Mr. Bobby Andrews Planning Coordinator, Representative, Tobago House of Assembly Ms. Lyra Hollingsworth- Thompson Coordinator, National Alcohol and Drug Abuse Prevention Programme, Ministry of Health Mr. Philip Ryan President, Trinidad and Tobago National Council on Alcoholism and Other Addictions Mr. John Aboud Representative, Chamber of Industry and Commerce Mr. Jefferson Jurawan Clinical psychologist, Rebirth House